Whereas C-reactive protein (CRP) is a validated marker of cardiovascular disease in serum [50], elevated levels of salivary CRP are also associated with CVD incidence, and using CRP has been proposed as a non-invasive and accessible method in the future assessment of cardiovascular risk and systemic inflammation [59,60]. The gene discussed is CRP; the disease is cardiovascular disorder.